Literature DB >> 3880576

Characterization of monoclonal antibodies to Treponema pallidum.

S A Lukehart, M R Tam, J Hom, S A Baker-Zander, K K Holmes, R C Nowinski.   

Abstract

Thirteen hybrid cell lines which produce mouse monoclonal antibodies to Treponema pallidum, the causative agent of syphilis, have been established. All of the monoclonal antibodies react with T. pallidum, Nichols strain, in ELISA and in immunofluorescence assays, but do not react with normal rabbit testicular tissue in the ELISA. Two of these antibodies were demonstrated to react with the nonpathogenic treponemes T. phagedenis, biotype Reiter, T. refringens (Noguchi strain), T. vincentii, and T. denticola (strains 11 and W), as well as with Borrelia recurrentis, Leptospira interrogans, serogroup Canicola, and the swine pathogen T. hyodysenteriae. The remaining 11 antibodies react with four recently isolated strains of T. pallidum, but with none of the related nonpathogens nor with Borrelia or Leptospira. Thus, our results to date indicate that these monoclonal antibodies may identify antigenic determinants that are specific either for T. pallidum alone or for those treponemes which are pathogenic for humans. The molecular specificities of six of the 13 antibodies were determined by Western blotting. We anticipate potential usefulness of these antibodies in the investigation of the antigenic structure of T. pallidum, the taxonomic study of the pathogenic and nonpathogenic treponemes, and in the diagnosis of syphilis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880576

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Detection of Treponema pallidum in early syphilis by DNA amplification.

Authors:  K Wicher; G T Noordhoek; F Abbruscato; V Wicher
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 3.  The endemic treponematoses.

Authors:  Lorenzo Giacani; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

4.  T-Cell responses to Treponema pallidum subsp. pallidum antigens during the course of experimental syphilis infection.

Authors:  T W Arroll; A Centurion-Lara; S A Lukehart; W C Van Voorhis
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Expression in Escherichia coli of the 37-kilodalton endoflagellar sheath protein of Treponema pallidum by use of the polymerase chain reaction and a T7 expression system.

Authors:  R D Isaacs; J D Radolf
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Structure and expression of the FlaA periplasmic flagellar protein of Borrelia burgdorferi.

Authors:  Y Ge; C Li; L Corum; C A Slaughter; N W Charon
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

7.  Detection of Treponema pallidum in lesion exudate with a pathogen-specific monoclonal antibody.

Authors:  E W Hook; R E Roddy; S A Lukehart; J Hom; K K Holmes; M R Tam
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

8.  Flagellins, but not endoflagellar sheath proteins, of Treponema pallidum and of pathogen-related oral spirochetes are glycosylated.

Authors:  C Wyss
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Phylogenetic analysis of pathogen-related oral spirochetes.

Authors:  B K Choi; C Wyss; U B Göbel
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

10.  Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering.

Authors:  Yuki Iwayanagi; Tomoyuki Igawa; Atsuhiko Maeda; Kenta Haraya; Naoko A Wada; Norihito Shibahara; Ken Ohmine; Takeru Nambu; Genki Nakamura; Futa Mimoto; Hitoshi Katada; Shunsuke Ito; Tatsuhiko Tachibana; Kou-ichi Jishage; Kunihiro Hattori
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.